Gene-wide tagging study of the association between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug resistance in epilepsy

被引：0
作者：
Kwan, Patrick [1 ]
Wong, Virginia [2 ]
Ng, Ping Wing [3 ]
Lui, Colin Hiu Tung [4 ]
Sin, Ngai Chuen [6 ]
Wong, Ka Sing [1 ]
Baum, Larry [5 ]
机构：
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Div Neurol, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Dept Paediat & Adalescent Med, Hong Kong, Hong Kong, Peoples R China
[3] United Christian Hosp, Dept Med & Geriatr, Div Neurol, Hong Kong, Hong Kong, Peoples R China
[4] Tseung Kwan O Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[5] Chinese Univ Hong Kong, Sch Pharm, Hong Kong, Hong Kong, Peoples R China
[6] Hosp Author Head Off, Hong Kong, Hong Kong, Peoples R China
来源：
PHARMACOGENOMICS | 2011年 / 12卷 / 03期
关键词：
ABCC2; ABCC5; ABCG2; antiepileptic drugs; drug resistance; epilepsy; pharmacogenomics; ANTIEPILEPTIC DRUGS; PROTEIN; CARBAMAZEPINE; TRANSPORT;
D O I：
10.2217/PGS.10.183
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Aim: To determine the association between polymorphisms of the multiclrug transporter genes ABCC2, ABCC5 and ABCG2, and drug resistance in epilepsy by genotyping comprehensive sets of tagging SNPs. Materials & methods: A total of 25 tagging SNPs from ABCC2, ABCC5 and ABCG2 genes were genotyped in a total of 590 Han Chinese epilepsy patients (262 drug resistant and 328 drug responsive). Genotype and allele distributions in drug-responsive and drug-resistant patients were compared. Results: Genotype distributions of all the selected SNPs were consistent with Hardy Weinberg equilibrium. None of the polymorphisms, either genotype or allele distributions, were significantly associated with drug resistance. For each gene, no haplotypes of over 1% frequency, and that included all SNPs of the gene, were associated with drug resistance. Conclusion: This gene-wide tagging study revealed no association between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug resistance in epilepsy.
引用
收藏
页码：319 / 325
页数：7
相关论文
共 36 条
  • [31] Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro
    Cihalova, Daniela
    Staud, Frantisek
    Ceckova, Martina
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (01) : 105 - 116
  • [32] Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: A Gynecologic Oncology Group study
    Tian, Chunqiao
    Ambrosone, Christine B.
    Darcy, Kathleen M.
    Krivak, Thomas C.
    Armstrong, Deborah K.
    Bookman, Michael A.
    Davis, Warren
    Zhao, Hua
    Moysich, Kirsten
    Gallion, Holly
    DeLoia, Julie A.
    GYNECOLOGIC ONCOLOGY, 2012, 124 (03) : 575 - 581
  • [33] Association between ABCG2 and SLCO1B1 polymorphisms and adverse drug reactions to regorafenib: a preliminary study
    Maeda, Akimitsu
    Ando, Hitoshi
    Ura, Takashi
    Komori, Azusa
    Hasegawa, Ayako
    Taniguchi, Hiroya
    Kadowaki, Shigenori
    Muro, Kei
    Tajika, Masahiro
    Kobara, Makiko
    Matsuzaki, Masahide
    Hashimoto, Naoya
    Maeda, Mieko
    Kojima, Yasushi
    Aoki, Masahiro
    Kondo, Eisaku
    Mizutani, Akiyoshi
    Fujimura, Akio
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (05) : 409 - 415
  • [34] Induction of the ABC-transporters Mdr1/P-gp (Abcb1), Mrp1 (Abcc1), and Bcrp (Abcg2) during establishment of multidrug resistance following exposure to mitoxantrone
    Nieth, C
    Lage, H
    JOURNAL OF CHEMOTHERAPY, 2005, 17 (02) : 215 - 223
  • [35] Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2
    Ferrari, Marco
    Guasti, Luigina
    Maresca, Andrea
    Mirabile, Mauro
    Contini, Sara
    Grandi, Anna Maria
    Marino, Franca
    Cosentino, Marco
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (05) : 539 - 547
  • [36] Genetic polymorphisms of CYP3A5, CHRM2, and ZNF498 and their association with epilepsy susceptibility: a pharmacogenetic and case-control study
    Al-Eitan, Laith N.
    Al-Dalalah, Islam M.
    Mustafa, Mohamed M.
    Alghamdi, Mansour A.
    Elshammari, Afrah K.
    Khreisat, Wael H.
    Al-Quasmi, Mohammed N.
    Aljamal, Hanan A.
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2019, 12 : 225 - 233
1234